A detailed history of Geode Capital Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,010,508 shares of AXGN stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,010,508
Previous 978,896 3.23%
Holding current value
$15 Million
Previous $7.09 Million 99.9%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.52 - $14.69 $237,722 - $464,380
31,612 Added 3.23%
1,010,508 $14.2 Million
Q2 2024

Aug 09, 2024

BUY
$5.67 - $8.06 $272,647 - $387,573
48,086 Added 5.17%
978,896 $7.09 Million
Q1 2024

May 13, 2024

BUY
$6.63 - $10.69 $228,562 - $368,527
34,474 Added 3.85%
930,810 $7.51 Million
Q4 2023

Feb 13, 2024

BUY
$3.61 - $7.76 $171,810 - $369,321
47,593 Added 5.61%
896,336 $6.12 Million
Q3 2023

Nov 13, 2023

BUY
$4.68 - $9.26 $125,260 - $247,843
26,765 Added 3.26%
848,743 $4.24 Million
Q2 2023

Aug 11, 2023

BUY
$8.5 - $10.38 $298,290 - $364,265
35,093 Added 4.46%
821,978 $7.5 Million
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $237,368 - $345,176
31,523 Added 4.17%
786,885 $7.44 Million
Q4 2022

Feb 13, 2023

BUY
$9.44 - $13.09 $126,382 - $175,248
13,388 Added 1.8%
755,362 $7.54 Million
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $170,069 - $255,939
20,893 Added 2.9%
741,974 $8.84 Million
Q2 2022

Aug 12, 2022

BUY
$6.99 - $10.0 $231,131 - $330,660
33,066 Added 4.81%
721,081 $5.91 Million
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $80,056 - $117,988
11,027 Added 1.63%
688,015 $5.46 Million
Q4 2021

Feb 11, 2022

BUY
$8.8 - $16.0 $588,860 - $1.07 Million
66,916 Added 10.97%
676,988 $6.34 Million
Q3 2021

Nov 12, 2021

SELL
$15.23 - $21.72 $219,342 - $312,811
-14,402 Reduced 2.31%
610,072 $9.64 Million
Q2 2021

Aug 13, 2021

BUY
$17.8 - $23.5 $477,200 - $630,011
26,809 Added 4.49%
624,474 $13.5 Million
Q1 2021

May 12, 2021

BUY
$17.18 - $22.6 $974,896 - $1.28 Million
56,746 Added 10.49%
597,665 $12.1 Million
Q4 2020

Feb 12, 2021

BUY
$11.5 - $17.96 $207,310 - $323,764
18,027 Added 3.45%
540,919 $9.68 Million
Q3 2020

Nov 13, 2020

SELL
$10.62 - $13.12 $103,778 - $128,208
-9,772 Reduced 1.83%
522,892 $6.08 Million
Q2 2020

Aug 13, 2020

BUY
$7.35 - $10.81 $234,354 - $344,676
31,885 Added 6.37%
532,664 $4.92 Million
Q1 2020

May 14, 2020

BUY
$8.38 - $17.34 $224,257 - $464,035
26,761 Added 5.65%
500,779 $5.21 Million
Q4 2019

Feb 13, 2020

BUY
$11.18 - $18.6 $156,475 - $260,325
13,996 Added 3.04%
474,018 $8.48 Million
Q3 2019

Nov 12, 2019

BUY
$12.09 - $20.46 $171,678 - $290,532
14,200 Added 3.19%
460,022 $5.74 Million
Q2 2019

Aug 14, 2019

BUY
$18.5 - $25.47 $537,295 - $739,725
29,043 Added 6.97%
445,822 $8.83 Million
Q1 2019

May 14, 2019

BUY
$14.62 - $22.13 $489,784 - $741,377
33,501 Added 8.74%
416,779 $8.78 Million
Q4 2018

Feb 13, 2019

BUY
$17.09 - $38.25 $480,416 - $1.08 Million
28,111 Added 7.91%
383,278 $7.83 Million
Q3 2018

Nov 13, 2018

BUY
$34.05 - $55.9 $740,349 - $1.22 Million
21,743 Added 6.52%
355,167 $13.1 Million
Q2 2018

Aug 14, 2018

BUY
$36.15 - $52.5 $2.18 Million - $3.17 Million
60,304 Added 22.08%
333,424 $16.8 Million
Q1 2018

May 15, 2018

BUY
$24.4 - $40.25 $373,808 - $616,630
15,320 Added 5.94%
273,120 $9.97 Million
Q4 2017

Feb 13, 2018

SELL
$18.5 - $28.6 $28,231 - $43,643
-1,526 Reduced 0.59%
257,800 $7.3 Million
Q3 2017

Nov 14, 2017

BUY
$14.65 - $19.35 $523,884 - $691,956
35,760 Added 16.0%
259,326 $5.02 Million
Q2 2017

Aug 14, 2017

BUY
N/A
223,566
223,566 $3.74 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $628M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.